Cytos Biotechnology AG to Host Investor and Analyst R&D Day in New York City
10/17/2013 11:53:03 AM
SCHLIEREN, ZURICH, Switzerland, October 17, 2013 /PRNewswire/ --
Cytos Biotechnology Ltd (SIX:CYTN) will host an Investor and Analyst R&D Day for institutional investors and research analysts on
Wednesday, October 23, 2013 from 8:00 a.m. to 10:00 a.m. ET in New York City
Christian Itin, Chairman and CEO as well as senior executives of Cytos will present on Cytos' lead program CYT003, which is in clinical development for the treatment of allergic asthma.
Help employers find you! Check out all the jobs and post your resume.
comments powered by